Global Pharmaceuticals & Biotech Leverage Leaders

Aether Industries

Market Cap: ₹195.8b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥350.7b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Sai Life Sciences

Market Cap: ₹269.8b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Aurobindo Pharma

Market Cap: ₹882.3b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Imeik Technology DevelopmentLtd

Market Cap: CN¥30.3b

Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.

Alkem Laboratories

Market Cap: ₹665.1b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥39.5b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Otsuka Holdings

Market Cap: JP¥5.8t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Stevanato Group

Market Cap: US$5.2b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Exelixis

Market Cap: US$14.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Corcept Therapeutics

Market Cap: US$9.7b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Nurix Therapeutics

Market Cap: US$2.4b

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Biogen

Market Cap: US$30.4b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.6t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

SCHOTT Pharma KGaA

Market Cap: €3.1b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Dianthus Therapeutics

Market Cap: US$5.8b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

ACADIA Pharmaceuticals

Market Cap: US$4.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Tasly Pharmaceutical Group

Market Cap: CN¥23.0b

Engages in the research, development, production, and sale of pharmaceuticals in China.

AtaiBeckley

Market Cap: US$2.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

D&D Pharmatech

Market Cap: ₩3.1t

Engages in the research and development and manufacturing of pharmaceuticals in South Korea.

Trevi Therapeutics

Market Cap: US$2.7b

A clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥56.6b

Asymchem Laboratories (Tianjin) Co., Ltd.

Vaxcyte

Market Cap: US$8.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Krka d. d

Market Cap: €8.1b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

3SBio

Market Cap: HK$40.3b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Sino Biopharmaceutical

Market Cap: HK$88.7b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Rubicon Research

Market Cap: ₹237.2b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Orion Oyj

Market Cap: €10.9b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥12.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Hanmi Pharm

Market Cap: ₩4.9t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

United Therapeutics

Market Cap: US$22.7b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Regeneron Pharmaceuticals

Market Cap: US$68.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Sanofi

Market Cap: €92.8b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Bachem Holding

Market Cap: CHF 5.3b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Camurus

Market Cap: SEK 37.4b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

CareDx

Market Cap: US$2.1b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.